Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
BHVN has a market cap or net worth of $2.52 billion. The enterprise value is $2.31 billion.
The last earnings date was Tuesday, November 14, 2023, after market close.
|Earnings Date||Nov 14, 2023|
BHVN has 80.08 million shares outstanding. The number of shares has increased by 73.51% in one year.
|Shares Change (YoY)||+73.51%|
|Shares Change (QoQ)||+0.11%|
|Owned by Insiders (%)||14.47%|
|Owned by Institutions (%)||100.97%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 5.00, with a Debt / Equity ratio of 0.10.
|Debt / Equity||0.10|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -110.10% and return on invested capital (ROIC) is -155.75%.
|Return on Equity (ROE)||-110.10%|
|Return on Assets (ROA)||-85.60%|
|Return on Capital (ROIC)||-155.75%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$2.30M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has increased by +118.18% in the last 52 weeks.
|52-Week Price Change||+118.18%|
|50-Day Moving Average||26.23|
|200-Day Moving Average||20.03|
|Relative Strength Index (RSI)||62.39|
|Average Volume (30 Days)||1,185,044|
Short Selling Information
The latest short interest is 6.72 million, so 8.39% of the outstanding shares have been sold short.
|Short Previous Month||7.12M|
|Short % of Shares Out||8.39%|
|Short % of Float||10.80%|
|Short Ratio (days to cover)||5.28|
|Earnings Per Share (EPS)||-$7.22|
The company has $240.62 million in cash and $28.29 million in debt, giving a net cash position of $212.34 million or $2.65 per share.
|Cash & Cash Equivalents||240.62M|
|Net Cash Per Share||$2.65|
|Equity / Book Value||290.01M|
|Book Value Per Share||3.62|
In the last 12 months, operating cash flow was -$292.25 million and capital expenditures -$2.88 million, giving a free cash flow of -$295.13 million.
|Operating Cash Flow||-292.25M|
|Free Cash Flow||-295.13M|
|FCF Per Share||-$4.32|
Dividends & Yields
BHVN does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for BHVN is $29.40, which is -6.49% lower than the current price. The consensus rating is "Strong Buy".
|Price Target Difference||-6.49%|
|Analyst Consensus||Strong Buy|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|